Posts tagged ‘NASDAQ:PBIO’
Pressure BioSciences (PBIO): How Much is It Really Worth?
Pressure BioSciences Inc. (NASDAQ: PBIO), a developer of proprietary lab instrumentation and associated consumables based on its game-changing Pressure Cycling Technology (PCT), providing equipment to companies like Thermo Fisher Scientific (NYSE: TMO) and Amgen Inc. (NASDAQ: AMGN), appears to be significantly undervalued by the market. Significant Growth Potential Ahead Pressure BioSciences is preparing to commercialize
Pressure BioSciences (PBIO): Highly Misunderstood, Significantly Undervalued
Pressure BioSciences Inc. (NASDAQ: PBIO), a developer of proprietary lab instrumentation and associated consumables based on its game-changing Pressure Cycling Technology (PCT), providing equipment to companies like Thermo Fisher Scientific (NYSE: TMO) and Amgen, Inc. (NASDAQ: AMGN), is a highly misunderstood and significantly undervalued stock. Pressure BioSciences’ Three Big Misunderstandings Investors face three key fears
Pressure BioSciences (PBIO): A Game-Changing Technology Platform
Pressure BioSciences Inc. (NASDAQ: PBIO) is a developer of proprietary laboratory instrumentation and associated consumables based on its game-changing Pressure Cycling Technology (PCT), competing against other companies in the sample preparation technology sector, like Qiagen NV (NASDAQ: QGEN) and Becton, Dickenson and Co. (NYSE: BDX). Simplifying and Improving Sample Preparation Lab sample preparation is often